57 related articles for article (PubMed ID: 16728984)
1. Molecular response in acute promyelocytic leukemia: a direct comparison of regular and real-time RT-PCR.
Liu YF; Zhu YM; Shen SH; Shen ZX; Li JM; Chen SJ; Chen Z; Jiong HU
Leukemia; 2006 Aug; 20(8):1393-9. PubMed ID: 16728984
[TBL] [Abstract][Full Text] [Related]
2. [Comparisons of conventional and normalized calculation of quantitative real-time RT-PCR detecting PML-RAR alpha fusion gene in patients with acute promyelocytic leukemia].
Hu J; Gao XD; Liu YF; Zhu YM; Li JM; Shen ZX
Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):304-7. PubMed ID: 18844066
[TBL] [Abstract][Full Text] [Related]
3. [Molecular responses in acute promyelocytic leukemia patients monitored by real-time quantitative RT-PCR].
Yao L; Chen ZX; Cen JN
Ai Zheng; 2008 Feb; 27(2):214-7. PubMed ID: 18279625
[TBL] [Abstract][Full Text] [Related]
4. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
[TBL] [Abstract][Full Text] [Related]
5. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
Gau JP; Young JH; Lin TH; Yang YS
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
[TBL] [Abstract][Full Text] [Related]
7. Impact of RT-PCR monitoring on the long-term survival in acute promyelocytic leukemia.
Hu J; Yu T; Zhao W; Gu B; Shen Z; Li X; Sun G; Chen S; Wang Z
Chin Med J (Engl); 2000 Oct; 113(10):899-902. PubMed ID: 11775836
[TBL] [Abstract][Full Text] [Related]
8. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
Barragán E; Bonanad S; López JA; Martín G; Martínez J; Sanz GF; Gomis F; Pérez ML; Senent ML; Larrea L; Bolufer P; Sanz MA
Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
[TBL] [Abstract][Full Text] [Related]
9. FLT3 overexpression in acute promyelocytic leukemia patients without detectable FLT3-ITD or codon 835-836 mutations: a pilot study.
Lilakos K; Viniou NA; Mavrogianni D; Vassilakopoulos TP; Dimopoulou MN; Plata E; Angelopoulou MK; Variami E; Stavrogianni N; Liapi D; Xilouri I; Galanopoulos A; Ageloudi M; Panayiotidis P; Voulgarelis M; Rombos J; Meletis J; Yataganas X; Pangalis GA
Anticancer Res; 2006; 26(2A):1201-7. PubMed ID: 16619525
[TBL] [Abstract][Full Text] [Related]
10. When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).
Cassinat B; de Botton S; Kelaidi C; Ades L; Zassadowski F; Guillemot I; Schlageter MH; Raffoux E; Harousseau JL; Legrand O; Escoffre-Barbe M; Reman O; Gardembas M; Himberlin C; Cahn JY; Guyotat D; Bouscary D; Parry A; Rousselot P; Baruchel A; Dombret H; Chevret S; Fenaux P; Chomienne C
Leuk Res; 2009 Sep; 33(9):1178-82. PubMed ID: 19167754
[TBL] [Abstract][Full Text] [Related]
11. Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.
Cassinat B; Guillemot I; Moluçon-Chabrot C; Zassadowski F; Fenaux P; Tournilhac O; Chomienne C
Haematologica; 2006 Dec; 91(12 Suppl):ECR58. PubMed ID: 17194664
[TBL] [Abstract][Full Text] [Related]
12. Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
Guerrasio A; Pilatrino C; De Micheli D; Cilloni D; Serra A; Gottardi E; Parziale A; Marmont F; Diverio D; Divona M; Lo Coco F; Saglio G
Leukemia; 2002 Jun; 16(6):1176-81. PubMed ID: 12040450
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R
Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol.
Noguera NI; Breccia M; Divona M; Diverio D; Costa V; De Santis S; Avvisati G; Pinazzi MB; Petti MC; Mandelli F; Lo Coco F
Leukemia; 2002 Nov; 16(11):2185-9. PubMed ID: 12399960
[TBL] [Abstract][Full Text] [Related]
15. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
[TBL] [Abstract][Full Text] [Related]
16. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F
Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
[TBL] [Abstract][Full Text] [Related]
17. RT-PCR in diagnosis and disease monitoring of acute promyelocytic leukemia (APL).
Grimwade D; Langabeer S; Howe K; Solomon E
Methods Mol Biol; 1998; 89():333-58. PubMed ID: 9664338
[No Abstract] [Full Text] [Related]
18. Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.
Viehmann S; Teigler-Schlegel A; Bruch J; Langebrake C; Reinhardt D; Harbott J
Leukemia; 2003 Jun; 17(6):1130-6. PubMed ID: 12764380
[TBL] [Abstract][Full Text] [Related]
19. [Monitoring of minimal residual disease in patients with acute promyelocytic leukemia].
Shuravina EN; Parovichnikova EN; Demidova IA; Misiurin AV; Isaev VG; Ol'shanskaia IuV; Savchenko VG
Ter Arkh; 2006; 78(7):25-31. PubMed ID: 16944747
[TBL] [Abstract][Full Text] [Related]
20. PML-RAR alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome.
Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
Int J Hematol; 1994 Oct; 60(3):197-205. PubMed ID: 7858239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
